soul
01-30-2007, 05:24 PM
----------------------------------------------------------------------------------------
Quote from Maureen Reeder
In MS Connections Jan-Feb 2007
“Engaging: We will engage those who
want to do something about MS now and
will consider different ideas even when they
challenge our own experiences.”
--------------------------------------------------------------------------------------
Inside MS National MS Society magazine Feb- March 2007
Marijuana merits study Dr. John Richert < Inside MS National MS Society magazine
Because Marijuana has been described as having therapeutic value for some of the symptoms that are so difficult to measure objectively, and because its study has suffered from the problems that we are discussing here. the national MS Society has convened a special task force to evaluate all of the current evidence for the efficacy of MJ for MS symptoms, and all the evidence relating to adverse effects. The task force will then determine if an appropriate risk: benefit analysis can be conducted or, alternatively, what additional research studies are needed to answer the open questions. If a drug with abuse potential is convincingly shown to have therapeutic benefit that significantly outweighs the risks, we must have valid data to convince the legal authorities that its use is justified.
To increase available data we have already initiated funding to our first grant to study the effects of cannabis on MS related spasticity. This trial is going forward thanks in no small part to improved methods for objectively measuring the severity of spasticity
As a physician and a leader in the national MS Society, I want you to know that we will follow what the best data tell us, pursue way’s to acquire more knowledge and push to make all treatments proven to be effective available to all who need them.
--------------------------------------------------------------------
Is it time to take action?
soul
Quote from Maureen Reeder
In MS Connections Jan-Feb 2007
“Engaging: We will engage those who
want to do something about MS now and
will consider different ideas even when they
challenge our own experiences.”
--------------------------------------------------------------------------------------
Inside MS National MS Society magazine Feb- March 2007
Marijuana merits study Dr. John Richert < Inside MS National MS Society magazine
Because Marijuana has been described as having therapeutic value for some of the symptoms that are so difficult to measure objectively, and because its study has suffered from the problems that we are discussing here. the national MS Society has convened a special task force to evaluate all of the current evidence for the efficacy of MJ for MS symptoms, and all the evidence relating to adverse effects. The task force will then determine if an appropriate risk: benefit analysis can be conducted or, alternatively, what additional research studies are needed to answer the open questions. If a drug with abuse potential is convincingly shown to have therapeutic benefit that significantly outweighs the risks, we must have valid data to convince the legal authorities that its use is justified.
To increase available data we have already initiated funding to our first grant to study the effects of cannabis on MS related spasticity. This trial is going forward thanks in no small part to improved methods for objectively measuring the severity of spasticity
As a physician and a leader in the national MS Society, I want you to know that we will follow what the best data tell us, pursue way’s to acquire more knowledge and push to make all treatments proven to be effective available to all who need them.
--------------------------------------------------------------------
Is it time to take action?
soul